CV vs INMD: stock comparison and AI forecast
Capsovision, Inc (CV) and Inmode Ltd. (INMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CV Capsovision, Inc
- Market Cap
- $342M
- P/E Ratio
- 8.1x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
INMD Inmode Ltd.
- Market Cap
- $760M
- P/E Ratio
- 6.7x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- INMD is 2.2 times larger than CV by market capitalization ($760M against $342M).
- INMD trades at 6.7 times trailing earnings, CV at 8.1 times.
- CV carries 0.41 times debt per unit of equity, against 0.12 times for INMD.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CV | INMD |
|---|---|---|
| Market Cap | $342M | $760M |
| P/E Ratio | 8.13x | 6.71x |
| P/B Ratio | 25.96x | 1.11x |
| EPS | $0.84 | $1.97 |
| Book Value/Share | $0.26 | $11.89 |
| Revenue/Share | $0.33 | – |
| FCF/Share | $-0.56 | – |
Profitability & Margins
| Metric | CV | INMD |
|---|---|---|
| ROE | – | 23.2% |
| ROA | – | 20.7% |
| ROIC | – | 21.2% |
| Gross Margin | 51.4% | 81.8% |
| Operating Margin | -213.1% | 34.5% |
| Net Margin | – | 37.1% |
| EBT Margin | -211.0% | 39.3% |
| Tax Rate | -0.1% | 5.7% |
Financial Health
| Metric | CV | INMD |
|---|---|---|
| Current Ratio | 3.35x | 9.88x |
| Quick Ratio | 2.44x | 8.83x |
| D/E Ratio | 0.41x | 0.12x |
| Financial Leverage | 1.41x | 1.12x |
| Interest Coverage | -534.6x | 41.5x |
| Working Capital | $12M | $628M |
Cash Flow
| Metric | CV | INMD |
|---|---|---|
| Operating Cash Flow | -$28M | $144M |
| Free Cash Flow | -$28M | – |
| Capital Spending | -$70K | – |
| FCF/Sales | -167.3% | – |
| CapEx/Sales | 0.4% | – |
Operational Efficiency
| Metric | CV | INMD |
|---|---|---|
| Asset Turnover | 0.90x | – |
| Receivables Turnover | 7.4x | – |
| Inventory Turnover | 1.7x | 1.1x |
| Fixed Assets Turnover | 29.7x | – |
| Days Sales Outstanding | 50 days | – |
| Days Inventory | 212 days | 347 days |
| Payables Period | 21 days | 84 days |
| Cash Conversion Cycle | 240 days | – |
Income Statement
| Metric | CV | INMD |
|---|---|---|
| Total Revenue | $17M | – |
| Operating Income | -$36M | $148M |
| Net Income | – | $159M |
| R&D Expense | $25M | $13M |
| SG&A Expense | $23M | $227M |
| Cost of Goods Sold | $8M | $78M |
Dividend & Shareholder Information
| Metric | CV | INMD |
|---|---|---|
| Shares Outstanding | 50M | 57M |
CV vs INMD: stock comparison and AI forecast
Which is bigger, CV or INMD?
INMD is 2.2 times larger than CV by market capitalization ($760M against $342M).
Which is cheaper on earnings, CV or INMD?
INMD trades at 6.7 times trailing earnings, CV at 8.1 times.
Which one does Intratio's AI model rank higher, CV or INMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.